Literature DB >> 34229846

Approaching Alcohol Use Disorder After Liver Transplantation for Acute Alcoholic Hepatitis.

Peng-Sheng Ting1, Ahmet Gurakar2, Jason Wheatley3, Geetanjali Chander4, Andrew M Cameron5, Po-Hung Chen6.   

Abstract

Severe alcoholic hepatitis portends a high risk of mortality without liver transplantation. Transplant outcomes in patients with severe alcoholic hepatitis exhibit a strong inverse association with post-transplant alcohol relapse. The ingredients most central to ameliorating alcohol relapse risk may include destigmatized post-transplant alcohol monitoring, a nonpunitive clinician-patient partnership, and multimodal therapies to maintain abstinence and mitigate high-risk drinking. We here review the core principles of post-liver transplant management specific to alcohol use disorder.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol use disorder; Behavioral treatment; Hepatitis; Liver transplantation; Motivational interviewing; Outcomes; Pharmacologic therapy

Mesh:

Year:  2021        PMID: 34229846      PMCID: PMC8264137          DOI: 10.1016/j.cld.2021.03.008

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.265


  84 in total

1.  Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score.

Authors:  Brian P Lee; Eric Vittinghoff; Christine Hsu; Hyosun Han; George Therapondos; Oren K Fix; David W Victor; Deepti Dronamraju; Gene Y Im; Michael D Voigt; John P Rice; Michael R Lucey; Sheila Eswaran; Po-Hung Chen; Zhiping Li; Haripriya Maddur; Norah A Terrault
Journal:  Hepatology       Date:  2019-03-05       Impact factor: 17.425

2.  Introducing the 2019 American Association for the Study of Liver Diseases Guidance on Alcohol-Associated Liver Disease.

Authors:  Michael Ronan Lucey; Gene Y Im; Jessica L Mellinger; Gyongyi Szabo; David W Crabb
Journal:  Liver Transpl       Date:  2019-08-21       Impact factor: 5.799

3.  Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis.

Authors:  John P Rice; Jens Eickhoff; Rashmi Agni; Aiman Ghufran; Rinjal Brahmbhatt; Michael R Lucey
Journal:  Liver Transpl       Date:  2013-12       Impact factor: 5.799

Review 4.  Nalmefene for treatment of alcohol dependence.

Authors:  Michael Soyka; Susanne Rösner
Journal:  Expert Opin Investig Drugs       Date:  2010-09-25       Impact factor: 6.206

5.  A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation.

Authors:  Robert M Weinrieb; Deborah H A Van Horn; Kevin G Lynch; Michael R Lucey
Journal:  Liver Transpl       Date:  2011-05       Impact factor: 5.799

6.  Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.

Authors:  Brian P Lee; Sumeyye Samur; Ozden O Dalgic; Emily D Bethea; Michael R Lucey; Ethan Weinberg; Christine Hsu; Mary E Rinella; Gene Y Im; Oren K Fix; George Therapondos; Hyosun Han; David W Victor; Michael D Voigt; Sheila Eswaran; Norah A Terrault; Jagpreet Chhatwal
Journal:  Gastroenterology       Date:  2019-04-15       Impact factor: 22.682

7.  Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials.

Authors:  Molly Magill; Lara A Ray
Journal:  J Stud Alcohol Drugs       Date:  2009-07       Impact factor: 2.582

8.  Longitudinal assessment of mortality risk among candidates for liver transplantation.

Authors:  Robert M Merion; Robert A Wolfe; Dawn M Dykstra; Alan B Leichtman; Brenda Gillespie; Philip J Held
Journal:  Liver Transpl       Date:  2003-01       Impact factor: 5.799

Review 9.  A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels.

Authors:  Michael F Fleming; Raymond F Anton; Claudia D Spies
Journal:  Alcohol Clin Exp Res       Date:  2004-09       Impact factor: 3.455

10.  Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.

Authors:  M Soyka; M Friede; J Schnitker
Journal:  Pharmacopsychiatry       Date:  2016-02-04       Impact factor: 5.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.